These outcomes, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the notion of targeting ACKR3 as a singular strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. By ticking this box and https://hubbardc160spk1.bloggactivo.com/profile